113 related articles for article (PubMed ID: 32043400)
1. Longitudinal kidney function outcome in aging testicular cancer survivors.
Nome RV; Cvancarova Småstuen M; Bjøro T; Kiserud CE; Fosså SD
Acta Oncol; 2020 Apr; 59(4):467-474. PubMed ID: 32043400
[No Abstract] [Full Text] [Related]
2. Thyroid hypofunction in aging testicular cancer survivors.
Nome RV; Småstuen MC; Fosså SD; Kiserud CE; Åsvold BO; Bjøro T
Acta Oncol; 2021 Nov; 60(11):1452-1458. PubMed ID: 34351829
[TBL] [Abstract][Full Text] [Related]
3. Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study.
Fosså SD; Dahl AA; Myklebust TÅ; Kiserud CE; Nome R; Klepp OH; Brydøy M; Haugnes HS
Cancer Epidemiol; 2020 Aug; 67():101744. PubMed ID: 32652337
[TBL] [Abstract][Full Text] [Related]
4. Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.
Feldman DR; Ardeshir-Rouhani-Fard S; Monahan P; Sesso HD; Fung C; Williams AM; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Zaid MA; Lipshultz SE; Einhorn LH; Oeffinger KC; Travis LB; Fossa SD;
Clin Genitourin Cancer; 2018 Aug; 16(4):e761-e769. PubMed ID: 29534941
[TBL] [Abstract][Full Text] [Related]
5. The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-up.
Skalleberg J; Småstuen MC; Oldenburg J; Osnes T; Fosså SD; Bunne M
Laryngoscope; 2020 Sep; 130(9):E515-E521. PubMed ID: 32065408
[TBL] [Abstract][Full Text] [Related]
6. Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective.
Fosså SD; Haugnes HS; Dahl AA; Kiserud CE; Fosså A; Skalleberg J; Myklebust TÅ
Ann Oncol; 2023 Dec; 34(12):1165-1174. PubMed ID: 37739265
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
Sprauten M; Brydøy M; Haugnes HS; Cvancarova M; Bjøro T; Bjerner J; Fosså SD; Oldenburg J
J Clin Oncol; 2014 Feb; 32(6):571-8. PubMed ID: 24419125
[TBL] [Abstract][Full Text] [Related]
8. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer.
Mykletun A; Dahl AA; Haaland CF; Bremnes R; Dahl O; Klepp O; Wist E; Fosså SD
J Clin Oncol; 2005 May; 23(13):3061-8. PubMed ID: 15860864
[TBL] [Abstract][Full Text] [Related]
9. Chronic cancer-related fatigue in long-term survivors of testicular cancer.
Orre IJ; Fosså SD; Murison R; Bremnes R; Dahl O; Klepp O; Loge JH; Wist E; Dahl AA
J Psychosom Res; 2008 Apr; 64(4):363-71. PubMed ID: 18374735
[TBL] [Abstract][Full Text] [Related]
10. Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.
Hjelle LV; Gundersen POM; Hellesnes R; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Bremnes RM; Haugnes HS
Acta Oncol; 2018 Oct; 57(10):1392-1400. PubMed ID: 29775128
[TBL] [Abstract][Full Text] [Related]
11. Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors.
Sprauten M; Haugnes HS; Brydøy M; Kiserud C; Tandstad T; Bjøro T; Bjerner J; Cvancarova M; Fosså SD; Oldenburg J
Ann Oncol; 2015 Oct; 26(10):2133-40. PubMed ID: 26265167
[TBL] [Abstract][Full Text] [Related]
12. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.
Nord C; Bjøro T; Ellingsen D; Mykletun A; Dahl O; Klepp O; Bremnes RM; Wist E; Fosså SD
Eur Urol; 2003 Sep; 44(3):322-8. PubMed ID: 12932930
[TBL] [Abstract][Full Text] [Related]
13. Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment.
Nord C; Olofsson SE; Glimelius I; Cedermark GC; Ekberg S; Cavallin-Ståhl E; Neovius M; Jerkeman M; Smedby KE
Acta Oncol; 2015 Nov; 54(10):1770-80. PubMed ID: 25833328
[TBL] [Abstract][Full Text] [Related]
14. A study of coping in long-term testicular cancer survivors.
Rutskij R; Gaarden T; Bremnes R; Dahl O; Finset A; Fossa SD; Klepp O; Sorebo O; Wist E; Dahl AA
Psychol Health Med; 2010 Mar; 15(2):146-58. PubMed ID: 20391232
[TBL] [Abstract][Full Text] [Related]
15. A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors.
Dahl CF; Haugnes HS; Bremnes R; Dahl O; Fosså SD; Klepp O; Wist E; Dahl AA
J Cancer Surviv; 2010 Sep; 4(3):256-65. PubMed ID: 20574815
[TBL] [Abstract][Full Text] [Related]
16. Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.
Fung C; Sesso HD; Williams AM; Kerns SL; Monahan P; Abu Zaid M; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Kollmannsberger CK; Cook R; Althouse S; Ardeshir-Rouhani-Fard S; Lipshultz SE; Einhorn LH; Fossa SD; Travis LB;
J Clin Oncol; 2017 Apr; 35(11):1211-1222. PubMed ID: 28240972
[TBL] [Abstract][Full Text] [Related]
17. Objective and subjective predictors of cancer-related stress symptoms in testicular cancer survivors.
Fleer J; Sleijfer D; Hoekstra H; Tuinman M; Klip E; Hoekstra-Weebers J
Patient Educ Couns; 2006 Dec; 64(1-3):142-50. PubMed ID: 16480847
[TBL] [Abstract][Full Text] [Related]
18. Fatigue, anxiety, and depression in long-term survivors of testicular cancer.
Fosså SD; Dahl AA; Loge JH
J Clin Oncol; 2003 Apr; 21(7):1249-54. PubMed ID: 12663711
[TBL] [Abstract][Full Text] [Related]
19. Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer.
Nord C; Fosså SD; Egeland T
Br J Cancer; 2003 Jan; 88(1):36-41. PubMed ID: 12556956
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
